164 related articles for article (PubMed ID: 15334543)
1. Structural integrity and expression of the L3MBTL gene in normal and malignant hematopoietic cells.
MacGrogan D; Kalakonda N; Alvarez S; Scandura JM; Boccuni P; Johansson B; Nimer SD
Genes Chromosomes Cancer; 2004 Nov; 41(3):203-13. PubMed ID: 15334543
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the imprinted polycomb gene L3MBTL, a candidate 20q tumour suppressor gene, in patients with myeloid malignancies.
Bench AJ; Li J; Huntly BJ; Delabesse E; Fourouclas N; Hunt AR; Deloukas P; Green AR
Br J Haematol; 2004 Dec; 127(5):509-18. PubMed ID: 15566354
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
4. Stage- and lineage-specific expression of the HOXA10 homeobox gene in normal and leukemic hematopoietic cells.
Lawrence HJ; Sauvageau G; Ahmadi N; Lopez AR; LeBeau MM; Link M; Humphries K; Largman C
Exp Hematol; 1995 Oct; 23(11):1160-6. PubMed ID: 7556525
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 20 deletions in myeloid malignancies: reduction of the common deleted region, generation of a PAC/BAC contig and identification of candidate genes. UK Cancer Cytogenetics Group (UKCCG).
Bench AJ; Nacheva EP; Hood TL; Holden JL; French L; Swanton S; Champion KM; Li J; Whittaker P; Stavrides G; Hunt AR; Huntly BJ; Campbell LJ; Bentley DR; Deloukas P; Green AR
Oncogene; 2000 Aug; 19(34):3902-13. PubMed ID: 10952764
[TBL] [Abstract][Full Text] [Related]
6. Low expression of the putative tumour suppressor gene gravin in chronic myeloid leukaemia, myelodysplastic syndromes and acute myeloid leukaemia.
Boultwood J; Pellagatti A; Watkins F; Campbell LJ; Esoof N; Cross NC; Eagleton H; Littlewood TJ; Fidler C; Wainscoat JS
Br J Haematol; 2004 Aug; 126(4):508-11. PubMed ID: 15287943
[TBL] [Abstract][Full Text] [Related]
7. L3mbtl, the mouse orthologue of the imprinted L3MBTL, displays a complex pattern of alternative splicing and escapes genomic imprinting.
Li J; Bench AJ; Piltz S; Vassiliou G; Baxter EJ; Ferguson-Smith AC; Green AR
Genomics; 2005 Oct; 86(4):489-94. PubMed ID: 16081246
[TBL] [Abstract][Full Text] [Related]
8. A human homolog of Drosophila lethal(3)malignant brain tumor (l(3)mbt) protein associates with condensed mitotic chromosomes.
Koga H; Matsui S; Hirota T; Takebayashi S; Okumura K; Saya H
Oncogene; 1999 Jul; 18(26):3799-809. PubMed ID: 10445843
[TBL] [Abstract][Full Text] [Related]
9. Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.
Liu TX; Becker MW; Jelinek J; Wu WS; Deng M; Mikhalkevich N; Hsu K; Bloomfield CD; Stone RM; DeAngelo DJ; Galinsky IA; Issa JP; Clarke MF; Look AT
Nat Med; 2007 Jan; 13(1):78-83. PubMed ID: 17159988
[TBL] [Abstract][Full Text] [Related]
10. Folylpoly-gamma-glutamate synthetase gene mRNA splice variants and protein expression in primary human leukemia cells, cell lines, and normal human tissues.
Leclerc GJ; Barredo JC
Clin Cancer Res; 2001 Apr; 7(4):942-51. PubMed ID: 11309345
[TBL] [Abstract][Full Text] [Related]
11. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
12. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
13. A heterozygous frameshift mutation in the Fanconi anemia C gene in familial T-ALL and secondary malignancy.
Rischewski JR; Clausen H; Leber V; Niemeyer C; Ritter J; Schindler D; Schneppenheim R
Klin Padiatr; 2000; 212(4):174-6. PubMed ID: 10994546
[TBL] [Abstract][Full Text] [Related]
14. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
15. Multiple splicing variants of Naf1/ABIN-1 transcripts and their alterations in hematopoietic tumors.
Shiote Y; Ouchida M; Jitsumori Y; Ogama Y; Matsuo Y; Ishimaru F; Tanimoto M; Shimizu K
Int J Mol Med; 2006 Nov; 18(5):917-23. PubMed ID: 17016622
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of hypermethylation of cell cycle control and DNA-mismatch repair genes in low-density and CD34+ bone marrow cells from patients with myelodysplastic syndrome.
Hofmann WK; Takeuchi S; Takeuchi N; Thiel E; Hoelzer D; Koeffler HP
Leuk Res; 2006 Nov; 30(11):1347-53. PubMed ID: 16682076
[TBL] [Abstract][Full Text] [Related]
17. SCL expression at critical points in human hematopoietic lineage commitment.
Zhang Y; Payne KJ; Zhu Y; Price MA; Parrish YK; Zielinska E; Barsky LW; Crooks GM
Stem Cells; 2005; 23(6):852-60. PubMed ID: 15917481
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive characterization of annexin I alterations in esophageal squamous cell carcinoma.
Hu N; Flaig MJ; Su H; Shou JZ; Roth MJ; Li WJ; Wang C; Goldstein AM; Li G; Emmert-Buck MR; Taylor PR
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6013-22. PubMed ID: 15447985
[TBL] [Abstract][Full Text] [Related]
19. Imprinting of the human L3MBTL gene, a polycomb family member located in a region of chromosome 20 deleted in human myeloid malignancies.
Li J; Bench AJ; Vassiliou GS; Fourouclas N; Ferguson-Smith AC; Green AR
Proc Natl Acad Sci U S A; 2004 May; 101(19):7341-6. PubMed ID: 15123827
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathways mediating MDS/AML with focus on AML1/RUNX1 point mutations.
Harada Y; Harada H
J Cell Physiol; 2009 Jul; 220(1):16-20. PubMed ID: 19334039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
